Transcode Therapeutics, Inc.
RNAZ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829635
No open-market purchases or sales by Transcode Therapeutics, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $208.1K in total; no superinvestor holds it.
Holders of 5% or more of RNAZ
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Transcode Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| CK Life Sciences Intl (Holdings) Inc | 13D/A | 83.90%14.1M shares | 0.00 ppfrom 83.90% | Oct 16, 20256 filings | Aug 3, 2026 | SEC |
| Unleash Immuno Oncolytics, Inc. | 13G | 9.94%300.0K shares | New | Jul 28, 20261 filing | Jul 28, 2026 | SEC |
| YA II PN, Ltd. | 13G | 9.90%101.8K shares | New | Apr 20, 20261 filing | Apr 20, 2026 | SEC |
| Braci Elena Rosa | 13G | 6.17%186.2K shares | New | Jul 28, 20261 filing | Jul 28, 2026 | SEC |
| Katzman Daniel Eduardo | 13G | 5.16%155.6K shares | New | Jul 28, 20261 filing | Jul 28, 2026 | SEC |
| Tracy Thomas Joseph | 13D | 5.00%35.0K shares | New | Mar 20, 20251 filing | Mar 20, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
24 Schedule 13D and 13G filings on Transcode Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 3, 20264:38 PM ET | CK Life Sciences Intl (Holdings) Incand 1 other | 13D/A | 83.90%14.1M shares | 0.00 ppfrom 83.90% | Aug 3, 2026 | SEC |
| Jul 28, 20267:51 PM ET | Unleash Immuno Oncolytics, Inc. | 13G | 9.94%300.0K shares | New | Jul 23, 2026 | SEC |
| Jul 28, 20267:50 PM ET | Braci Elena Rosa | 13G | 6.17%186.2K shares | New | Jul 23, 2026 | SEC |
| Jul 28, 20267:48 PM ET | Katzman Daniel Eduardo | 13G | 5.16%155.6K shares | New | Jul 23, 2026 | SEC |
| Jul 27, 20264:15 PM ET | CK Life Sciences Intl (Holdings) Incand 1 other | 13D/A | 83.90%14.1M shares | +74.00 ppfrom 9.90% | Jul 27, 2026 | SEC |
| Jul 23, 20264:15 PM ET | CK Life Sciences Intl (Holdings) Incand 1 other | 13D/A | 9.90%300.0K shares | +1.10 ppfrom 8.80% | Jul 23, 2026 | SEC |
| Jul 17, 20264:15 PM ET | CK Life Sciences Intl (Holdings) Incand 1 other | 13D/A | 8.80%83.3K shares | −0.30 ppfrom 9.10% | Jul 17, 2026 | SEC |
| Apr 20, 20264:56 PM ET | YA II PN, Ltd.and 7 others | 13G | 9.90%101.8K shares | New | Apr 15, 2026 | SEC |
| Jan 7, 202612:38 PM ET | Sabby Management, LLCand 2 others | 13G/A | 4.90%41.6K shares | −5.00 ppfrom 9.90%Below 5% | Dec 31, 2025 | SEC |
| Nov 10, 20252:16 PM ET | Goldman Sachs Group Incand 1 other | 13G/A | 0.00%82 shares | −5.90 ppfrom 5.90%Below 5% | Sep 30, 2025 | SEC |
| Oct 28, 20255:39 PM ET | CK Life Sciences Intl (Holdings) Incand 1 other | 13D/A | 9.10%83.3K shares | 0.00 ppfrom 9.10% | Oct 27, 2025 | SEC |
| Oct 16, 20254:05 PM ET | CK Life Sciences Intl (Holdings) Incand 1 other | 13D | 9.10%83.3K shares | New | Oct 8, 2025 | SEC |
| Aug 14, 20259:55 PM ET | Anson Funds Management LPand 5 others | 13G/A | 0.10%27.1K shares | −9.80 ppfrom 9.90%Below 5% | Jun 30, 2025 | SEC |
| Aug 14, 20252:16 PM ET | Goldman Sachs Group Incand 1 other | 13G | 5.90%49.0K shares | New | Jun 30, 2025 | SEC |
| Mar 20, 20255:16 PM ET | Tracy Thomas Joseph | 13D | 5.00%35.0K shares | New | Mar 7, 2025 | SEC |
| Feb 14, 20255:16 PM ET | Anson Funds Management LPand 4 others | 13G | 9.90%113.5K shares | New | Dec 31, 2024 | SEC |
| Jan 3, 20257:25 PM ET | Sabby Management, LLCand 2 others | 13G | 9.90%69.6K shares | New | Dec 31, 2024 | SEC |
| Feb 10, 2023 | Medarova Zdravka | 13G/AOld format | – | – | – | SEC |
| Dec 20, 2022 | Dudley Robert Michael | 13DOld format | – | – | – | SEC |
| Dec 20, 2022 | Medarova Zdravka | 13GOld format | – | New | – | SEC |
| Dec 20, 2022 | Dudley Robert Michael | 13GOld format | – | New | – | SEC |
| Oct 27, 2022 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| Jul 21, 2021 | Hirschman Orin | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Transcode Therapeutics, Inc. shares.
No Form 144 notices for Transcode Therapeutics, Inc. are on file.